Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950116-98-001817
Filing Date
1998-09-01
Accepted
1998-09-01 00:00:00
Documents
1
Group Members
HAROLD R. WERNERHEALTHCARE PARTNERS II, L.P.HEALTHCARE PARTNERS III, L.P.HEALTHCARE PARTNERS IV, L.P.HEALTHCARE VENTURES II LPHEALTHCARE VENTURES II, L.P.HEALTHCARE VENTURES III, L.P.HEALTHCARE VENTURES IV, L.P.JAMES H. CAVANAUGH, PH.D.JOHN W. LITTLECHILD
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 FORM SC 13G SC 13G 50628
  Complete submission text file 0000950116-98-001817.txt   53220
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02194-2725 6174330771
AVANT IMMUNOTHERAPEUTICS INC (Subject) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37761 | Film No.: 98701942
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address TWIN TOWERS AT METRO PARK 379 THORNALL AVENUE EDISON NJ 08837
Business Address TWIN TOWERS AT METRO PARK 379 THORNALL AVENUE EDISON NJ 08837 9089064613
HEALTHCARE VENTURES II LP (Filed by) CIK: 0000859649 (see all company filings)

EIN.: 223015728 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 0000